Neuronetics STIM Medical Device — Gross Profit
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Neuronetics in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuronetics's medical device — gross profit.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuronetics's medical device — gross profit?
- Neuronetics (STIM) reported medical device — gross profit of $10.07M in Q1 2026.
- How has Neuronetics's medical device — gross profit changed year-over-year?
- Neuronetics's medical device — gross profit decreased by 1.0% year-over-year, from $10.17M to $10.07M.
- What is the long-term trend for Neuronetics's medical device — gross profit?
- Over 3 years (2022 to 2025), Neuronetics's medical device — gross profit has grown at a -2.8% compound annual growth rate (CAGR), from $49.72M to $45.72M.
- What does medical device — gross profit mean?
- Gross profit is calculated as total segment revenue minus the direct costs of goods and services sold. It measures the fundamental profitability of the medical device segment before accounting for operating expenses, reflecting the company's ability to manage production costs relative to pricing.